CAN-FITE BIOPHA/S (NYSEAMERICAN:CANF)’s share price shot up 9.8% during mid-day trading on Wednesday . The stock traded as high as $1.62 and last traded at $1.35. 1,243,592 shares changed hands during mid-day trading, an increase of 410% from the average session volume of 244,009 shares. The stock had previously closed at $1.23.

Separately, Zacks Investment Research cut shares of CAN-FITE BIOPHA/S from a “buy” rating to a “hold” rating in a research report on Tuesday, February 5th.

ILLEGAL ACTIVITY NOTICE: “CAN-FITE BIOPHA/S (CANF) Shares Up 9.8%” was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this story on another website, it was stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this story can be read at


Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological, and liver diseases. The company's lead drug candidate is CF101 (Piclidenoson), which is in Phase III clinical trials for the treatment of rheumatoid arthritis and psoriasis.

Featured Story: Understanding Average Daily Trade Volume

Receive News & Ratings for CAN-FITE BIOPHA/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CAN-FITE BIOPHA/S and related companies with's FREE daily email newsletter.